WPRIM Management System> DCMS> Journal of Stroke> 2020> 22

Volume: 22

1. Cerebral Microbleeds in Autosomal Dominant Polycystic Kidney Disease Page:153—156
2. Comparison of Awareness of Stroke Warning Signs between Community-Dwelling Stroke Survivors and Families and the General Population without Stroke Page:150—152
3. Hospital Volume Threshold Associated with Higher Survival after Endovascular Recanalization Therapy for Acute Ischemic Stroke Page:141—149
4. Timing of Recanalization and Functional Recovery in Acute Ischemic Stroke Page:130—140
5. Visit-to-Visit Variability of Lipids Measurements and the Risk of Stroke and Stroke Types: A Prospective Cohort Study Page:119—129
6. Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial Page:108—118
7. Association of Low Blood Pressure with White Matter Hyperintensities in Elderly Individuals with Controlled Hypertension Page:99—107
8. Association between Hemoglobin A1c and Stroke Risk in Patients with Type 2 Diabetes Page:87—98
9. Prevalence of Intracranial Aneurysm in Patients with Aortopathy: A Systematic Review with Meta-Analyses Page:76—86
10. Pathophysiologic and Therapeutic Perspectives Based on Thrombus Histology in Stroke Page:64—75
11. Rewiring the Lesioned Brain: Electrical Stimulation for Post-Stroke Motor Restoration Page:47—63
12. Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets Page:29—46
13. Depression after Subarachnoid Hemorrhage: A Systematic Review Page:11—28
14. Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms Page:1—10
15. Mechanisms of Stroke in Coronavirus Disease 2019 Page:282—283
16. Management of Hyperacute Stroke during the Coronavirus Disease of 2019 Pandemic: The Modified Code Stroke in a Medical Center in Taiwan Page:278—281
17. Stroke in the Time of Coronavirus Disease 2019: Experience of Two University Stroke Centers in Egypt Page:275—277
18. “Direct” Mechanical Thrombectomy in Acute Ischemic Stroke during Percutaneous Coronary Intervention Page:271—274
19. Left Atrial Appendage Occlusion: An Alternative to Triple Therapy in Stroke Patients Undergoing Carotid Angioplasty Page:268—270
20. Recurrent and Drastic Increase in Dabigatran Levels May Be Induced by Therapeutic Plasma Exchange Page:266—267
21. Five-Year Cumulative Cost Saving with Thrombolysis in Korea: 3-Month Disability-Based Estimation Page:262—265
22. Sex Differences by Hospital-Level in Performance and Outcomes of Endovascular Treatment for Acute Ischemic Stroke Page:258—261
23. The Value of Transcranial Doppler Sonography in Hyperperfusion Syndrome after Carotid Artery Stenting: A Nationwide Prospective Study Page:254—257
24. Outcome of Stroke Patients with Cancer and Nonbacterial Thrombotic Endocarditis Page:245—253
25. Endovascular Treatment in Patients with Cerebral Artery Occlusion of Three Different Etiologies Page:234—244
26. Perfusion Imaging to Select Patients with Large Ischemic Core for Mechanical Thrombectomy Page:225—233
27. Left Ventricular Hypertrophy and Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis Page:206—224
28. Unfavorable Vascular Anatomy during Endovascular Treatment of Stroke: Challenges and Bailout Strategies Page:185—202
29. Association between Intracranial Arterial Dolichoectasia and Cerebral Small Vessel Disease and Its Underlying Mechanisms Page:173—184
30. Beyond the Brain: The Systemic Pathophysiological Response to Acute Ischemic Stroke Page:159—172
31. Coronavirus Disease 2019 and Stroke Page:157—158
32. Management of Acute Stroke Patients Amid the Coronavirus Disease 2019 Pandemic: Scientific Statement of the Korean Stroke Society Page:203—205
33. Beyond the Brain: The Systemic Pathophysiological Response to Acute Ischemic Stroke Page:424—424
34. The Life of Professor C. Miller Fisher: A Giant of Stroke Medicine Page:422—423
35. Response to Letter by Dr. Ajay Malhotra Page:421—421
36. Letter to the Editor Regarding “Prevalence of Intracranial Aneurysm in Patients with Aortopathy: A Systematic Review with Meta-Analyses” Page:419—420
37. Blood Pressure Lowering Decreases Intracerebral Hemorrhage Volume and Improves Behavioral Outcomes in Experimental Animals Page:416—418
38. National Trends in Clinical Outcomes of Endovascular Therapy for Ischemic Stroke in South Korea between 2008 and 2016 Page:412—415
39. Maintenance of Stroke Care Quality amid the Coronavirus Disease 2019 Outbreak in Taiwan Page:407—411
40. Reliability and Clinical Utility of Machine Learning to Predict Stroke Prognosis: Comparison with Logistic Regression Page:403—406
41. Early Fluid Attenuation Inversion Recovery Sulcal Contrast Enhancement Correlates with Severity of Reversible Cerebral Vasoconstriction Syndrome Page:400—402
42. Nurse Led Smartphone Electrographic Monitoring for Atrial Fibrillation after Ischemic Stroke: SPOT-AF Page:387—395
43. Decision-Making Visual Aids for Late, Imaging-Guided Endovascular Thrombectomy for Acute Ischemic Stroke Page:377—386
44. Serum Neurofilament Light Chain Is Associated with Incident Lacunes in Progressive Cerebral Small Vessel Disease Page:369—376
45. Liver Enzymes and Risk of Stroke: The Atherosclerosis Risk in Communities (ARIC) Study Page:357—368
46. Geographic Variations of Stroke Incidence in Chinese Communities: An 18-Year Prospective Cohort Study from 1997 to 2015 Page:345—356
47. Long-Term Survival after Stroke in 1.4 Million Japanese Population: Shiga Stroke and Heart Attack Registry Page:336—344
48. Stroke in Coronavirus Disease 2019: A Systematic Review Page:324—335
49. Mothership versus Drip-and-Ship Model for Mechanical Thrombectomy in Acute Stroke: A Systematic Review and Meta-Analysis for Clinical and Radiological Outcomes Page:317—323
50. Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences Page:306—316
51. Optimizing Stem Cell Therapy after Ischemic Brain Injury Page:286—305
52. The Impact of Our High Impact Factor Page:285—285
53. Long-Term Trends in Ischemic Stroke Incidence and Risk Factors: Perspectives from an Asian Stroke Registry Page:396—399